Henry Schein (HSIC) : Capital Management Associates Ny reduced its stake in Henry Schein by 33.33% during the most recent quarter end. The investment management company now holds a total of 4,000 shares of Henry Schein which is valued at $661,840 after selling 2,000 shares in Henry Schein , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Henry Schein makes up approximately 1.08% of Capital Management Associates Ny’s portfolio.
Other Hedge Funds, Including , Ahl Partners Llp reduced its stake in HSIC by selling 15,709 shares or 74.66% in the most recent quarter. The Hedge Fund company now holds 5,333 shares of HSIC which is valued at $882,398. Henry Schein makes up approx 0.05% of Ahl Partners Llp’s portfolio.Green Valley Investors reduced its stake in HSIC by selling 88,434 shares or 16.31% in the most recent quarter. The Hedge Fund company now holds 453,851 shares of HSIC which is valued at $75,094,186. Henry Schein makes up approx 2.20% of Green Valley Investors’s portfolio.Blackrock Institutional Trust Company N.a. reduced its stake in HSIC by selling 12,897 shares or 0.55% in the most recent quarter. The Hedge Fund company now holds 2,330,046 shares of HSIC which is valued at $385,529,411. Henry Schein makes up approx 0.06% of Blackrock Institutional Trust Company N.a.’s portfolio.Three Peaks Capital Management boosted its stake in HSIC in the latest quarter, The investment management firm added 1,319 additional shares and now holds a total of 29,995 shares of Henry Schein which is valued at $5,007,965. Henry Schein makes up approx 0.84% of Three Peaks Capital Management’s portfolio.First Niagara Bank reduced its stake in HSIC by selling 75 shares or 2.56% in the most recent quarter. The Hedge Fund company now holds 2,859 shares of HSIC which is valued at $511,790. Henry Schein makes up approx 0.14% of First Niagara Bank’s portfolio.
Henry Schein closed down -0.81 points or -0.49% at $162.98 with 3,41,373 shares getting traded on Thursday. Post opening the session at $163.92, the shares hit an intraday low of $162.28 and an intraday high of $164.31 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
On the company’s financial health, Henry Schein reported $1.64 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $1.63. The company had revenue of $2872.60 million for the quarter, compared to analysts expectations of $2845.09 million. The company’s revenue was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.
Henry Schein Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products laboratory products equipment repair services branded and generic pharmaceuticals vaccines surgical products diagnostic tests infection-control products and vitamins among others. The Company’s global technology and value-added services segment provides software technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis e-services practice technology network and hardware services as well as continuing education services for practitioners.